https://www.globenewswire.com/fr/news-release/2025/06/24/3104106/18362/en/amarin-announces-exclusive-license-and-supply-agreement-with-recordati-to-commercialize-vazkepa-icosapent-ethyl-in-europe.html
Amarin Announces Exclusive License and Supply Agreement
-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive...
exclusive licenseamarinannouncessupplyagreement
https://www.businesswire.com/news/home/20211122006522/en/Arrowhead-Pharmaceuticals-Enters-Exclusive-License-Agreement-with-GSK-for-ARO-HSD
Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD
Arrowhead Pharmaceuticals and GlaxoSmithKline sign exclusive license agreement for RNAi candidate ARO-HSD against NASH
exclusive license agreementarrowhead pharmaceuticalsenters
https://www.biospace.com/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-gensci-for-the-commercialization-of-camcevi-tm-in-china
Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of...
Nov 17, 2020 - Foresee Pharmaceuticals announced that it has entered into an exclusive license agreement with GenScience Pharmaceuticals - a wholly-owned subsidiary of...
exclusive license agreement
https://www.prnewswire.co.uk/news-releases/avecho-and-sandoz-enter-exclusive-license-and-development-agreement-to-commercialise-cbd-for-insomnia-in-australia-302390766.html
Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for...
Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for...
exclusive license
https://www.gilead.com/news/news-details/2022/kite-and-refuge-biotechnologies-announce-exclusive-license-agreement-for-investigational-gene-expression-platform-for-blood-cancers
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene...
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers
exclusive license agreementkiterefugebiotechnologiesannounce
https://www.prnewswire.com/news-releases/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader-301608317.html
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel...
/PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced today that it and its wholly owned subsidiary company, Shanghai Jemincare...
exclusive license agreement
https://www.businesswire.com/news/home/20250820660089/en/BioSkryb-Genomics-Secures-Exclusive-License-to-Breakthrough-Methylation-Patent-to-Enable-the-First-Single-Cell-Five-Base-Genome
BioSkryb Genomics Secures Exclusive License to Breakthrough Methylation Patent to Enable the First...
BioSkryb announced the execution of an exclusive license to a patent co-owned by Stanford University and the Chan Zuckerberg Biohub San Francisco.
exclusive license
https://www.businesswire.com/news/home/20230620687501/en/Biolinq-and-Taisho-Pharmaceutical-Announce-Strategic-Collaboration-and-Exclusive-License-Agreement-in-Japan
Biolinq and Taisho Pharmaceutical Announce Strategic Collaboration and Exclusive License Agreement...
Biolinq Incorporated, a medtech company that is developing novel biosensing technologies, has signed an exclusive license agreement with Taisho Pharmaceutica...
taisho pharmaceuticalstrategic collaborationexclusive licenseannounceagreement
https://www.biospace.com/press-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases
Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation...
exclusive license agreement
https://www.globenewswire.com/news-release/2025/01/22/3013133/0/en/ArriVent-BioPharma-Enters-Exclusive-License-with-Lepu-Biopharma-for-MRG007-an-Antibody-Drug-Conjugate-for-the-treatment-of-Gastrointestinal-Cancers.html
ArriVent BioPharma Enters Exclusive License with Lepu
Exclusive global license outside of Greater China for MRG007, a novel antibody drug conjugate (ADC) in development for gastrointestinal (GI) cancersFirst...
exclusive licensebiopharmaenters
https://www.biospace.com/press-releases/transpire-bio-enters-into-exclusive-license-agreement-with-suzhou-intragrand-pharma-for-investigational-pde4-inhibitor
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for...
exclusive license agreement
https://www.merck.com/bdl_item/merck-and-kelun-biotech-announce-exclusive-license-and-collaboration-agreement-for-seven-investigational-antibody-drug-conjugate-candidates-for-the-treatment-of-cancer/
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven...
May 31, 2024 - Merck, known as MSD outside of the United States and Canada, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), a...
exclusive licensecollaboration agreementmerckkelunbiotech
https://www.biospace.com/degron-therapeutics-announces-multi-target-collaboration-and-exclusive-license-agreement-with-takeda-to-discover-molecular-glue-degraders
Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with...
Jul 17, 2024 - Degron Therapeutics, the company using its molecular glue-based targeted protein degradation drug-discovery platform to advance human health, announced it has...
exclusive license agreementdegrontherapeuticsannouncesmulti
https://www.prnewswire.co.uk/news-releases/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-accord-healthcare-876861376.html
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
/PRNewswire/ -- An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program (leuprorelin depot),...
exclusive license agreementforeseepharmaceuticalsentersaccord
https://spaceref.com/status-report/nasa-notice-of-intent-to-grant-an-exclusive-license-mindrum-precision/
NASA Notice of intent to grant an exclusive license: Mindrum Precision - SpaceRef
Dec 23, 2009 - Space news and reference site.
notice of intent
https://www.merck.com/news/merck-enters-exclusive-worldwide-license-agreement-with-teijin-pharma-for-investigational-antibody-candidate-targeting-tau/
Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody...
May 11, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into an exclusive worldwide license agreement with...
license agreement
https://www.prnewswire.com/news-releases/gb-sciences-obtains-exclusive-worldwide-license-on-a-time-released-cannabinoid-formulation-for-neuropathic-pain-300537302.html
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for...
/PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid...
https://www.prnewswire.com/news-releases/moberg-pharma-and-taisho-sign-exclusive-license-agreement-for-mob-015-in-japan-300927822.html
Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and...
exclusive license agreement
https://www.prnewswire.co.uk/news-releases/targovax-grants-iovaxis-3-months-extension-to-the-exclusive-license-option-for-tg-mutant-ras-vaccines-in-greater-china-and-singapore-888254913.html
Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS...
/PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today...
https://www.businesswire.com/news/home/20240506079856/en/Xeris-Enters-Into-an-Exclusive-Worldwide-Collaboration-and-License-Agreement-with-Beta-Bionics
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commerciali...
https://www.lawinsider.com/contracts/tagged/non-exclusive-unlimited-pro-license-agreement
Non-Exclusive Unlimited Pro License Agreement Sample Contracts | Law Insider
Non-Exclusive Unlimited Pro License Agreement sample contracts and agreements.
non exclusivepro licensesample contractsunlimitedagreement
https://finviz.com/news/339567/2020-biolabs-announces-exclusive-us-license-agreement-with-rokit-healthcare-to-integrate-advanced-ckd-prediction-technology-into-its-longevity-test-program
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate...
Stock screener for investors and traders, financial visualizations.
https://finviz.com/news/345019/aligos-therapeutics-enters-into-exclusive-license-deal-with-xiamen-amoytop-biotech-co-ltd-to-develop-and-commercialize-pevifoscorvir-sodium-in-greater-china-for-chronic-hepatitis-b-virus-infection
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to...
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/press-releases/vor-bio-enters-into-exclusive-global-license-agreement-with-remegen-for-late-stage-autoimmune-asset
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset...
https://www.bondluxuryliving.com/
License to Live at the Bond in Jack London Square! | Exclusive Listing of Annie Tegner Compass...
License to Live at The Bond! This two-bedroom, two-bath corner condo offers 1,260 sq ft of sleek, urban sophistication in the heart of Jack London Square. Just...
https://spaceref.com/status-report/nasa-notice-of-intent-to-grant-an-exclusive-license-syneren-technologies-corporation/
NASA Notice of Intent To Grant an Exclusive License: Syneren Technologies Corporation - SpaceRef
Nov 27, 2012 - Space news and reference site.
notice of intent
https://www.prnewswire.com/news-releases/wize-pharma-enters-exclusive-license-agreement-for-ophthalmic-non-viral-gene-therapy-technology-300914052.html
Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology
/PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced...
exclusive license agreement
https://www.prnewswire.com/news-releases/cboe-and-gemini-enter-into-exclusive-global-license-agreement-to-use-bitcoin-market-data-300498072.html
CBOE and Gemini Enter Into Exclusive Global License Agreement to Use Bitcoin Market Data
/PRNewswire/ -- CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE) and Gemini Trust Company, LLC (Gemini) today announced an agreement that provides Chicago...
https://www.prnewswire.com/news-releases/inmagene-and-kissei-enter-into-an-exclusive-license-agreement-for-fostamatinib-in-china-301345936.html
Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China
/PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") and Kissei Pharmaceutical Co., Ltd. ("Kissei") announced today that they have entered into an...
exclusive license agreement
https://www.gilead.com/news/news-details/2000/gilead-sciences-and-eyetech-pharmaceuticals-announce-exclusive-license-of-potential-new-therapy-for-age-related-macular-degeneration
Gilead Sciences and EyeTech Pharmaceuticals Announce Exclusive License of Potential New Therapy for...
Gilead Sciences and EyeTech Pharmaceuticals Announce Exclusive License of Potential New Therapy for Age Related Macular Degeneration